Central nervous system action of melatonin on gastric acid and pepsin secretion in pylorus-ligated rats.
We recently demonstrated that centrally administered melatonin at low doses inhibits the induction of gastric lesions by water-immersion restraint stress. To investigate the mechanism of the potent anti-ulcer action of melatonin, the central nervous system (CNS) effects of melatonin on gastric acid and pepsin secretion were studied in conscious pylorus-ligated rats. Intracisternal (i.c.) melatonin (1-100 ng) dose-dependently decreased acid and pepsin output, while a higher i.p. dose (1 microg) had no inhibitory effect. The i.c. melatonin did not change serum gastrin concentrations. Serum melatonin concentrations at 1 and 4 h after i.c. administration of 10-100 ng melatonin did not differ from those in rats receiving i.c. vehicle. The present results suggest that melatonin administered centrally modulates the secretion of gastric acid and pepsin which may explain, at least in part, the protective, anti-stress role of melatonin in the gastric mucosa observed in our previous study.
Kato
K
K
3rd Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Murai
I
I
Asai
S
S
Takahashi
Y
Y
Matsuno
Y
Y
Komuro
S
S
Kurosaka
H
H
Iwasaki
A
A
Ishikawa
K
K
Arakawa
Y
Y
D000758:Anesthesia; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects*; D002946:Cisterna Magna; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism / Q000502:physiology; D005755:Gastrins / Q000097:blood; D007267:Injections; D007274:Injections, Intraperitoneal; D008297:Male; D008550:Melatonin / Q000008:administration & dosage / Q000494:pharmacology*; D010434:Pepsin A / Q000378:metabolism*; D011708:Pylorus / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014520:Urethane
D000975:Antioxidants; D005755:Gastrins; D014520:Urethane; D010434:Pepsin A; D008550:Melatonin